Shytomel 25, Liothyronine Sodium, Hormones & Menopausal, Online Pharmacy, ZarvyPharm
AntiCancer Drugs HORMONES Thyroid Cancer Thyroid Hormone

Shytomel 25

★★★★★
★★★★★
0

(0)

Generic For CYTOMEL
Active Ingredient LIOTHYRONINE SODIUM
Strength 25MCG
Manufacturer KACHHELA MEDEX
Shytomel 25 box and tablet bottle, front-facing label visible
Shytomel 25 box and tablet bottle close-up with label readable
Two Shytomel 25 boxes and bottle arranged flat, product name and packaging visible
Shytomel 25 box and tablet bottle, front-facing label visible
Shytomel 25 box and tablet bottle close-up with label readable
Two Shytomel 25 boxes and bottle arranged flat, product name and packaging visible
Best available coupon applied for preview!
Use code ZARVY26 at checkout to get 15% OFF your order.
COUPON CODE
ZARVY26
15% OFF
Pack Size Price Per Unit Unit Price QTY CART Best Coupon Price
MAX DISCOUNT
1 BOX - 100 TABLETS $ 0.52 $ 52.00
$ 44.20
Apply ZARVY26 (-15%)
You save $ 7.80
2 BOXES - 200 TABLETS $ 0.45
13% $ 104.00
$ 90.00
$ 76.50
Apply ZARVY26 (-15%)
You save $ 13.50
★ Best Value 3 BOXES - 300 TABLETS $ 0.40
23% $ 156.00
$ 120.00
$ 102.00
Apply ZARVY26 (-15%)
You save $ 18.00

Exchange & Returns Information

 

 

Reference

Reference information will be available soon.

Product Description

Shytomel 25 contains liothyronine sodium (T3) 25 mcg, the active thyroid hormone formulation used when rapid metabolic effect or precise T3 replacement/suppression is required. Liothyronine is indicated for patients with inadequate T4→T3 conversion, treatment-resistant hypothyroidism, short-term TSH suppression in differentiated thyroid cancer follow-up, and selected acute hypothyroid states.

Because T3 has a faster onset and greater potency than T4, dosing requires careful titration and regular monitoring—especially in elderly or cardiovascular-compromised patients. Distributed via reputable online pharmacy channels.

Indications & Uses

  • HORMONES & MENOPAUSAL SYMPTOMS | Thyroid Hormone
    Primary/secondary/tertiary hypothyroidism where T3 replacement or supplementation is indicated.
    TSH suppression for differentiated thyroid cancer surveillance and goiter reduction.
    Acute severe hypothyroidism/myxedema in specialist/hospital settings (IV formulations used as appropriate).
    Diagnostic thyroid suppression testing (specialist use).

Benefits & Effectiveness

  • Liothyronine is identical to endogenous T3 and directly increases cellular metabolic rate, oxygen consumption, and protein synthesis by activating nuclear thyroid hormone receptors.
  • Produces rapid symptomatic improvement (energy, cognition, thermoregulation, GI motility) and prompt TSH suppression when required for short-term protocols.
  • Short half-life enables fine dose titration for individualized regimens, but increases the need for frequent monitoring and cautious up-titration.

Directions for Use

  • Adult hypothyroidism (oral): Start 25 mcg once daily; increase by 25 mcg every 1–2 weeks as tolerated. Typical maintenance 25–75 mcg/day.
  • Myxedema / severe hypothyroidism (oral titration): Start low (e.g., 5 mcg/day), increase cautiously; maintenance often 50–100 mcg/day depending on response.
  • Myxedema coma (IV, hospital only): Initial 25–50 mcg IV once (use 10–20 mcg IV if cardiac risk); repeat/escalate guided by clinical response—avoid exceeding 100 mcg/day in early treatment.
  • TSH suppression / diagnostic protocols: Short-term regimens (e.g., 75–100 mcg/day for specific tests) only under specialist supervision.
  • Geriatric/cardiac risk patients: Start 5 mcg/day, titrate in 5 mcg increments every 1–2 weeks with cardiac monitoring.
  • Monitoring: Regularly check TSH/free T3, heart rate, blood pressure, and clinical symptoms. Adjust dose conservatively in cardiovascular disease.

Storage

  • Store below 30°C in a dry, light-protected container. Keep tightly closed and out of reach of children. Discard tablets that are discolored, chipped, or expired.
 

Possible Side Effects

  • Common: tremor, nervousness, palpitations, insomnia, sweating, diarrhea.
  • Serious / dose-related: cardiac arrhythmias, angina, exacerbation of ischemic heart disease, heart failure decompensation. Long-term overtreatment may accelerate bone loss (osteoporosis risk).
  • Precautions: Slow titration in elderly or cardiac patients; avoid abrupt withdrawal in severe cases; consult specialist for major dose changes.

FAQs

Shytomel contains liothyronine (T3), which acts faster and is more potent than levothyroxine (T4). It’s used in cases where rapid hormonal response is needed or T4 alone is insufficient.
Yes, it’s often used alongside levothyroxine in combination therapy, especially in patients with persistent symptoms despite normal TSH on T4 alone.
Effects may begin within a few days due to T3’s rapid action, but full hormonal balance takes several weeks of consistent dosing and monitoring.
Yes, but with caution. Start with lower doses and increase slowly to minimize cardiac risk.
No. Stopping suddenly can lead to hypothyroid rebound or, in severe cases, myxedema. Always follow your doctor’s tapering instructions.

Ratings & Reviews

Reviewed by 0 Users

0/5
★★★★★
★★★★★
5★
0%
4★
0%
3★
0%
2★
0%
1★
0%

Write a Review:

✓ The 'Write a Review' button appears only when an order includes this product and the product item in that order is marked as 'Delivered'.

✓ Clicking the button will redirect you to 'My Account > Orders > Orders Processing', where you can leave a review for a delivered item.

💡 Each product item can be reviewed only once, after it has been marked as 'Delivered'.


Multiple orders:

✓ If you bought this product more than once on different days, you can write a separate review for each order.

💡 When Order A is marked 'Delivered', the button takes you to Order A's details page.

Later, when Order B is also marked Delivered, the button stays active and takes you to Order B's details page for another review.

No reviews yet. Be the first to review this product!

Alternatives

Combo Deals

No combo deals available at the moment.